Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,822,169
-$775,441 QoQ
Shares Held
158,728
-14.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#709
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUST CO OF VERMONT holds $143,988,175 across 14 Drug Manufacturers - General names. PFE ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
212,013 | $53,844,941 | |
| 2 | ABBV |
AbbVie Inc.
|
162,450 | $40,878,917 | |
| 3 | MRK |
Merck & Co., Inc.
|
106,435 | $13,676,897 | |
| 4 | LLY |
ELI LILLY & Co
|
8,529 | $10,229,939 | |
| 5 | AMGN |
Amgen Inc
|
22,744 | $8,236,057 | |
| 6 | NVS |
Novartis AG
|
46,466 | $7,282,150 | |
| 7 | PFE |
Pfizer Inc
This page
|
158,728 | $3,822,169 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
49,346 | $2,843,316 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,822,169 | 158,728 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $4,597,610 | 184,643 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $5,521,999 | 216,719 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $5,965,245 | 246,091 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $7,158,169 | 282,485 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $8,582,878 | 323,516 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $11,811,079 | 408,123 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $11,244,602 | 401,880 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $10,748,295 | 387,326 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $9,204,422 | 319,709 | Shares | Sole | 2024-03-08 | |
| 2023-09-30 | $12,258,968 | 369,580 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $12,472,446 | 340,034 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $12,557,423 | 307,780 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $15,061,433 | 293,939 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $12,517,635 | 286,052 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $14,861,964 | 283,463 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $15,194,804 | 293,506 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $18,055,659 | 305,769 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $12,471,566 | 289,969 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $11,539,864 | 294,685 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $10,226,134 | 282,256 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $10,001,239 | 271,699 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $9,336,433 | 254,399 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $7,881,165 | 241,014 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $9,374,390 | 287,206 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||